1. Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature
    Carlo A. Liverani et al, 2020, Journal of Oncology CrossRef
  2. Diet and cancer of the esophagus and stomach
    Shu Wen Tay et al, 2021 CrossRef
  3. CERVICAL CANCER SCREENING INVITATIONS IN LOW AND MIDDLE INCOME COUNTRIES: EVIDENCE FROM ARMENIA
    Armenak Antinyan et al, 2021, Social Science & Medicine CrossRef
  4. A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression
    Rhafaela Lima Causin et al, 2021, Cells CrossRef
  5. LncRNA MORT (ZNF667-AS1) in Cancer—Is There a Possible Role in Gynecological Malignancies?
    Riccardo Di Fiore et al, 2021, IJMS CrossRef
  6. Caractéristiques épidémiologiques et histopathologiques de 1280 cancers du col utérin à Kinshasa
    J.-C. Kajimina Katumbayi et al, 2021, Gynécologie Obstétrique Fertilité & Sénologie  CrossRef
  7. HIV-Associated Cancer Biomarkers: A Requirement for Early Diagnosis
    Zodwa Dlamini et al, 2021, IJMS CrossRef
  8. Factors associated with and socioeconomic inequalities in breast and cervical cancer screening among women aged 15–64 years in Botswana
    Mpho Keetile et al, 2021, PLoS ONE CrossRef
  9. Low-cost, chromatic confocal endomicroscope for cellular imaging in vivo
    Nachiket Kulkarni et al, 2021, Biomed. Opt. Express CrossRef
  10. Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives
    Ying Tang et al, 2021, Molecular Therapy - Oncolytics CrossRef
  11. Immunological responses and anti-tumor effects of HPV16/18 L1-L2-E7 multiepitope fusion construct along with curcumin and nanocurcumin in C57BL/6 mouse model
    Matin Kayyal et al, 2021, Life Sciences CrossRef
  12. Antigen Presenting Cells Link the Female Genital Tract Microbiome to Mucosal Inflammation, With Hormonal Contraception as an Additional Modulator of Inflammatory Signatures
    Elizabeth H. Byrne et al, 2021, Front. Cell. Infect. Microbiol. CrossRef
  13. Women’s Satisfaction with Cervical Cancer Screening Services and Associated Factors in Maternal Health Clinics of Jimma Town Public Health Facilities, Southwest Ethiopia
    Tigist Atnafu et al, 2021, CMAR CrossRef
  14. Promoting HPV vaccination on social media: interactive effects of threat, efficacy and social cues
    Liang Chen et al, 2021, Human Vaccines & Immunotherapeutics CrossRef
  15. Simple Hysterectomy for Patients with Stage IA2 Cervical Cancer: A Retrospective Cohort Study
    Qing Liu et al, 2021, CMAR CrossRef
  16. Worldwide initiatives to eliminate cervical cancer
    Sarikapan Wilailak et al, 2021, Int J Gynecol Obstet CrossRef
  17. MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL FEATURES OF SQUAMOUS CELL CARCINOMA OF THE CERVIX
    M. S. Lyndin et al, 2021, VPBM CrossRef
  18. Knowledge of cervical cancer risk factors among Palestinian women: a national cross-sectional study
    Mohamedraed Elshami et al, 2021, BMC Women's Health CrossRef
  19. Building a predictive model to assist in the diagnosis of cervical cancer
    Emmanuel Kwateng Drokow et al, 2021, Future Oncology CrossRef
  20. Cervical cancer prevention: Human papillomavirus testing as primary screening
    Shreya Desai et al, 2021, Cancer CrossRef
  21. Splenic oligometastasis from cervical adenocarcinoma three years after disease free survival: A case report and a review of literature
    Abdullah Saleh AlQattan et al, 2021, Annals of Medicine and Surgery CrossRef
  22. Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma
    Edoardo Colzani et al, 2021 CrossRef
  23. Implementing community-based human papillomavirus self-sampling with SMS text follow-up for cervical cancer screening in rural, southwestern Uganda
    Naima T Joseph et al, 2021, J Glob Health CrossRef
  24. Cervical Cancer: Formulation and Implementation of Govt of India Guidelines for Screening and Management
    Ravi Mehrotra et al, 2022, Indian J Gynecol Oncolog CrossRef
  25. Human papillomavirus genotype distribution in Ethiopia: an updated systematic review
    Awoke Derbie et al, 2022, Virol J CrossRef
  26. HDAC10 Inhibits Cervical Cancer Progression through Downregulating the HDAC10-microRNA-223-EPB41L3 Axis
    Yuan Yuan Gu et al, 2022, Journal of Oncology CrossRef
  27. An artificial intelligence‑assisted diagnostic system improves the accuracy of image diagnosis of uterine cervical lesions
    Yu Ito et al, 2021, Mol Clin Oncol CrossRef
  28. Meeting the challenges of cervical cancer screening and HPV vaccination in the UK
    Roxanne Westwood et al, 2022 CrossRef
  29. Targeting tumor cells with pyrazolo[3,4-d]pyrimidine scaffold: A literature review on synthetic approaches, structure activity relationship, structural and target-based mechanisms
    Mohamed A. Abdelgawad et al, 2022, Arabian Journal of Chemistry CrossRef
  30. Clinical advantage and outcomes of computed tomography‐based transvaginal hybrid brachytherapy performed only by sedation without general or saddle block anesthesia
    Noriyuki Okonogi et al, 2022, Cancer Reports CrossRef
  31. Role of Artificial Intelligence Interpretation of Colposcopic Images in Cervical Cancer Screening
    Seongmin Kim et al, 2022, Healthcare CrossRef
  32. A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis
    Peter Shaw et al, 2022, Genes CrossRef
  33. A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies
    Nasim Vahidfar et al, 2022, Cancers CrossRef
  34. Factors associated with persistence and clearance of HPV16/18 among rural Chinese women: a cohort study in Wufeng, Hubei province
    Shuqi Pan et al, 2022, Women & Health CrossRef
  35. Correlating Quantitative Para-Aortic Lymph Node Computed Tomography Parameters With Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Staging: Possible Solution for Resource Constrained Countries
    Paul D’Cunha et al, 2022, J Comput Assist Tomogr CrossRef
  36. DeepCyto: a hybrid framework for cervical cancer classification by using deep feature fusion of cytology images
    Swati Shinde et al, 2022, MBE CrossRef
  37. Enhancement of Conventional and Photodynamic Therapy for Treatment of Cervical Cancer with Cannabidiol
    Radmila Razlog et al, 2022, Integr Cancer Ther CrossRef
  38. Accelerated Epigenetic Age Among Women with Invasive Cervical Cancer and HIV-Infection in Nigeria
    Jonah Musa et al, 2022, Front. Public Health CrossRef
  39. Effect of substrate stiffness on the mechanical properties of cervical cancer cells
    Ying Zhuang et al, 2022, Archives of Biochemistry and Biophysics CrossRef
  40. Global online interest in cervical cancer care in the time of COVID-19: an infodemiology study
    Michelle Ann B. Eala et al, 2022, Gynecologic Oncology Reports CrossRef
  41. Cervical cancer screening among HIV-positive women in urban Uganda: a cross sectional study
    Najjuka Sarah Maria et al, 2022, BMC Women's Health CrossRef
  42. Establishment of prognostic risk model and drug sensitivity based on prognostic related genes of esophageal cancer
    Jingjing Dai et al, 2022, Sci Rep CrossRef
  43. Male Circumcision and Genital Human Papillomavirus (HPV) Infection in Males and Their Female Sexual Partners: Findings From the HPV Infection and Transmission Among Couples Through Heterosexual Activity (HITCH) Cohort Study
    Samantha B. Shapiro et al, 2022 CrossRef
  44. Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future
    Karla Alfaro et al, 2022, Cancers CrossRef
  45. High-burden Cancers in Middle-income Countries: A Review of Prevention and Early Detection Strategies Targeting At-risk Populations
    Anna J. Dare et al, 2021 CrossRef
  46. Review of the Standard and Advanced Screening, Staging Systems and Treatment Modalities for Cervical Cancer
    Siaw Shi Boon et al, 2022, Cancers CrossRef
  47. Application and Clinical Value of Machine Learning-Based Cervical Cancer Diagnosis and Prediction Model in Adjuvant Chemotherapy for Cervical Cancer: A Single-Center, Controlled, Non-Arbitrary Size Case-Control Study
    Yang Wang et al, 2022, Contrast Media & Molecular Imaging CrossRef
  48. Possible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030: a cross-sectional study
    Tofan Widya Utami et al, 2022, Clin Exp Vaccine Res CrossRef
  49. Artificial intelligence assisted cytological detection for early esophageal squamous epithelial lesions by using low‐grade squamous intraepithelial lesion as diagnostic threshold
    Bin Yao et al, 2022, Cancer Medicine CrossRef
  50. The Effect of Gambier Catechin Isolate on Cervical Cancer Cell Death (HeLa Cell Lines)
    Refa Rahmaddiansyah et al, 2022, Open Access Maced J Med Sci CrossRef
  51. Extraterrestrial Gynecology: Could Spaceflight Increase the Risk of Developing Cancer in Female Astronauts? An Updated Review
    Rosa Drago-Ferrante et al, 2022, IJMS CrossRef
  52. Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations: PREvention and SCReening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC)
    Marat Sultanov et al, 2022, BMC Public Health CrossRef
  53. Validation of a sustainable internationally monitored cervical cancer screening system using a visual smartphone inspection in Kinshasa, Democratic Republic of Congo
    Celine Tendobi et al, 2022, Int J Gynecol Cancer CrossRef
  54. Exploration of shared gene signature with development of pre-eclampsia and cervical cancer
    Tingting Yin et al, 2022, Front. Genet. CrossRef
  55. Potential role of human papillomavirus proteins associated with the development of cancer
    Dhanvee Balaji et al, 2022, VirusDis. CrossRef
  56. Role of Paper-Based Sensors in Fight against Cancer for the Developing World
    Amey Dukle et al, 2022, Biosensors CrossRef
  57. Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy
    Aisha Aziz et al, 2022, Journal of Biomaterials Science, Polymer Edition CrossRef
  58. Economic Evaluations of HPV Vaccination in Targeted Regions of Low- and Middle-Income Countries: A Systematic Review of Modelling Studies
    Dedy Frianto et al, 2022, IJWH CrossRef
  59. Histopathological profile of cervical punch biopsies and risk factors associated with high-grade cervical precancerous lesions and cancer in northwest Ethiopia
    Awoke Derbie et al, 2022, PLoS ONE CrossRef
  60. Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma
    Weiyu Zhang et al, 2022, Front. Oncol. CrossRef
  61. Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making
    Sikhumbuzo Mbatha et al, 2022, Biomedicines CrossRef
  62. Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review
    Masita Arip et al, 2022, Discov Onc CrossRef
  63. Circadian as a prognostic factor for radiation responses in patients with cervical cancer: A nested case‑control study
    Irwan Ramli et al, 2022, Oncol Rep CrossRef
  64. Cervical cancer in Ethiopia: a review of the literature
    Awoke Derbie et al, 2022, Cancer Causes Control CrossRef
  65. Self-collected versus medic-collected sampling for human papillomavirus testing among women in Lagos, Nigeria: a comparative study
    Ning Feng et al, 2022, BMC Public Health CrossRef
  66. Urinary phthalate metabolite and BPA concentrations in women with cervical cancer
    Susanna Edith Medellín-Garibay et al, 2022, Environ Sci Pollut Res CrossRef
  67. Incidence of cervical precancerous lesions and cervical cancer in Denmark from 2000 to 2019: Population impact of multi‐cohort vaccination against human papillomavirus infection
    Linea Landgrebe Ring et al, 2022, Intl Journal of Cancer CrossRef
  68. hsa‐mir‐133a‐2 promotes the proliferation and invasion of cervical cancer cells by targeting the LAMB3 ‐mediated PI3K / ATK pathway
    Xiaoyu Sui et al, 2022, Cancer Medicine CrossRef
  69. Perception of human papilloma virus (HPV) vaccination during the COVID-19 pandemic
    Ye Won Jung et al, 2022 CrossRef
  70. Performance of HPV testing, Pap smear and VIA in women attending cervical cancer screening in Kilimanjaro region, Northern Tanzania: a cross-sectional study nested in a cohort
    Alex Mremi et al, 2022, BMJ Open CrossRef
  71. null
    Michael Mncedisi Willie et al, 2022 CrossRef
  72. Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services
    Tafadzwa Dzinamarira et al, 2022, Int J Gynecol Cancer CrossRef
  73. Investigation of Curcumin-Loaded OA400 Nanoparticle’s Effect on the Expression of E6 and E7 Human Papilloma-Virus Oncogenes and P53 and Rb Factors in HeLa Cell Line
    Rezvaneh Vahedian Sadeghi et al, 2022, Iran J Pharm Res CrossRef
  74. Cervical human papillomavirus genotypes in a high HIV setting: A scoping review of a decade of human papillomavirus epidemiological research in Botswana
    Leabaneng Tawe et al, 2022, Front. Med. CrossRef
  75. YTHDF3 mediates HNF1α regulation of cervical cancer radio‐resistance by promoting RAD51D translation in an m6A ‐dependent manner
    Hui Du et al, 2022, The FEBS Journal CrossRef
  76. Safety and Acceptability of Three Ablation Treatments for High-Grade Cervical Precancer: Early Data From a Randomized Noninferiority Clinical Trial
    Montserrat Soler et al, 2022, JCO Global Oncology CrossRef
  77. Parents' Knowledge of and Attitude Toward the Human Papillomavirus Vaccine in the Western Region of Saudi Arabia
    Safa H Alkalash et al, 2022 CrossRef
  78. Dysregulated RUNX1 Predicts Poor Prognosis by Mediating Epithelialmesenchymal Transition in Cervical Cancer
    Ling-ling Zheng et al, 2022, CURR MED SCI CrossRef
  79. Income-based disparity in the risk distant-stage cervical cancer and mortality after introduction of a national cancer screening program
    Erdenetuya Bolormaa et al, 2022, Epidemiol Health CrossRef
  80. Acceptability of an integrated school-based HPV vaccination program within two districts of Tanzania: A qualitative descriptive study
    Dominique Guillaume et al, 2023, PLOS Glob Public Health CrossRef
  81. Technological advancements in cancer diagnostics: Improvements and limitations
    Akhil Pulumati et al, 2023, Cancer Reports CrossRef
  82. Top advances of the year: Cervical cancer
    Sarah E. Podwika et al, 2023, Cancer CrossRef